Close

content

Sheba Medical Center Treats First Patient with CAR-T Cell Immunotherapy Manufactured Using the Lonza Cocoon Platform

“Treatment of the first patient is a significant milestone for Lonza and demonstrates the Cocoon’s capability to manufacture patient-scale cellular immunotherapies in a cGMP...

Oxford University vaccine trial paused after participant falls ill

Final clinical trials for a coronavirus vaccine, developed by AstraZeneca and Oxford University, have been put on hold after a participant had a suspected...

Chugai and NTT DATA Complete Demonstration of AI-based Clinical Trial Efficiency Solution

Chugai Pharmaceutical Co., Ltd. and NTT DATA Corporation have conducted a demonstration test of a solution for improving the efficiency of clinical trial-related document...

GC Pharma Taps Small Molecule AI Expert Atomwise to Expand Hemophilia Franchise

Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery, announced a partnership with GC Pharma, a South Korean biopharmaceutical company...

Co-Diagnostics, Inc. Enters into Agreement with Arches Research to Expand COVID-19 Testing Services

Co-Diagnostics Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that it has entered into an...

INOVIO Adds Thermo Fisher Scientific To Global Manufacturing Consortium

INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced...

Avacta to Launch SARS-CoV-2 ELISA Laboratory Test

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory test for the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read